Markets

Sobi Q3 Adj. EBITA Rises

October 20, 2025 — 04:22 am EDT

Written by RTTNews.com for RTTNews

(RTTNews) - Swedish Orphan Biovitrum AB reported a third quarter loss of 2.89 billion Swedish kronor compared to profit of 1.46 billion kronor, prior year. Loss per share was 8.32 kronor compared to profit of 4.22 kronor. Adjusted EBITA was 3.67 billion kronor, up 24%. Adjusted EPS was 6.05 kronor compared to 4.31 kronor. Total revenue increased 13 percent, 21 percent at constant exchange rates, to 7.78 billion kronor. Revenue from the strategic portfolio grew by 39 percent at CER to 5.00 billion kronor.

For 2025, the company now expects revenue to grow at low double-digit percentage at CER, revised from prior guidance of high-single-digit. Adjusted EBITA margin is anticipated to be at mid-to-high 30s percentage of revenue, updated from prior outlook of mid-30s.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source

Tags

Markets
Stocks Mentioned

Latest Articles
Data is currently not available